Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLEKHG7 encodes a protein with both pleckstrin homology (PH) and Dbl homology (DH) domains, characteristic of guanine-nucleotide exchange factors (“GEFs”) for Rho-family small GTPases[1][3][5][7][8]. It functions in cellular signal transduction by activating Rho proteins through exchange of GDP for GTP, thereby regulating processes such as cytoskeletal organization, cell morphology, and migration[1][3][7]. PLEKHG7 is implicated in tissue-specific functions including airway mucociliary epithelium regulation and has been associated with diseases such as pulp degeneration and pontocerebellar hypoplasia[1][7]. Molecularly, it belongs to the PH domain-containing family G and shares homology with PLEKHG5[1][3]. At present, there are no approved therapeutic agents directly targeting PLEKHG7 nor established clinical biomarkers, but its signaling role may make it of potential interest for disease modulation in cancer and degenerative conditions[1][7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology and RhoGEF domain containing G7 (PLEKHG7).